日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study

Lifileucel肿瘤浸润淋巴细胞疗法治疗晚期黑色素瘤患者的长期疗效和安全性:C-144-01研究的5年分析

Medina, Theresa; Chesney, Jason A; Kluger, Harriet M; Hamid, Omid; Whitman, Eric D; Cusnir, Mike; Thomas, Sajeve S; Wermke, Martin; Domingo-Musibay, Evidio; Phan, Giao Q; Kirkwood, John M; Larkin, James; Weber, Jeffrey; Graf Finckenstein, Friedrich; Chou, Jeffrey; Gastman, Brian; Wu, Xiao; Fiaz, Rana; Sarnaik, Amod A

Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

Lifileucel,一种自体肿瘤浸润淋巴细胞单药疗法,用于治疗对免疫检查点抑制剂耐药的晚期非小细胞肺癌患者

Schoenfeld, Adam J; Lee, Sylvia M; Doger de Spéville, Bernard; Gettinger, Scott N; Häfliger, Simon; Sukari, Ammar; Papa, Sophie; Rodríguez-Moreno, Juan F; Graf Finckenstein, Friedrich; Fiaz, Rana; Catlett, Melissa; Chen, Guang; Qi, Rongsu; Masteller, Emma L; Gontcharova, Viktoria; He, Kai

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

利菲卢塞(一种一次性自体肿瘤浸润淋巴细胞 (TIL) 疗法)在免疫检查点抑制剂和靶向治疗后进展的晚期黑色素瘤患者中的疗效和安全性:C-144-01 研究连续队列的汇总分析

Chesney, Jason; Lewis, Karl D; Kluger, Harriet; Hamid, Omid; Whitman, Eric; Thomas, Sajeve; Wermke, Martin; Cusnir, Mike; Domingo-Musibay, Evidio; Phan, Giao Q; Kirkwood, John M; Hassel, Jessica C; Orloff, Marlana; Larkin, James; Weber, Jeffrey; Furness, Andrew J S; Khushalani, Nikhil I; Medina, Theresa; Egger, Michael E; Graf Finckenstein, Friedrich; Jagasia, Madan; Hari, Parameswaran; Sulur, Giri; Shi, Wen; Wu, Xiao; Sarnaik, Amod

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Lifileucel,一种肿瘤浸润淋巴细胞疗法,用于治疗转移性黑色素瘤

Sarnaik, Amod A; Hamid, Omid; Khushalani, Nikhil I; Lewis, Karl D; Medina, Theresa; Kluger, Harriet M; Thomas, Sajeve S; Domingo-Musibay, Evidio; Pavlick, Anna C; Whitman, Eric D; Martin-Algarra, Salvador; Corrie, Pippa; Curti, Brendan D; Oláh, Judit; Lutzky, Jose; Weber, Jeffrey S; Larkin, James M G; Shi, Wen; Takamura, Toshimi; Jagasia, Madan; Qin, Harry; Wu, Xiao; Chartier, Cecile; Graf Finckenstein, Friedrich; Fardis, Maria; Kirkwood, John M; Chesney, Jason A

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

纳武利尤单抗对比多西他赛治疗晚期非鳞状非小细胞肺癌

Borghaei, Hossein; Paz-Ares, Luis; Horn, Leora; Spigel, David R; Steins, Martin; Ready, Neal E; Chow, Laura Q; Vokes, Everett E; Felip, Enriqueta; Holgado, Esther; Barlesi, Fabrice; Kohlhäufl, Martin; Arrieta, Oscar; Burgio, Marco Angelo; Fayette, Jérôme; Lena, Hervé; Poddubskaya, Elena; Gerber, David E; Gettinger, Scott N; Rudin, Charles M; Rizvi, Naiyer; Crinò, Lucio; Blumenschein, George R Jr; Antonia, Scott J; Dorange, Cécile; Harbison, Christopher T; Graf Finckenstein, Friedrich; Brahmer, Julie R

Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer

双重 IGF-1R/InsR 抑制剂 BMS-754807 与激素药物协同作用治疗雌激素依赖性乳腺癌

Xiaonan Hou, Fei Huang, Luciana F Macedo, Sean C Harrington, Karen A Reeves, Ann Greer, Friedrich Graf Finckenstein, Angela Brodie, Marco M Gottardis, Joan M Carboni, Paul Haluska